Sinovac Biotech Profile

Performance

Odds of Distress

Analyze Filter    Check how we calculate scores
Equity ratings for Sinovac Biotech Ltd are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 14, 2019 and ending today December 13, 2019. Click here to learn more.
Sinovac Biotech Ltd cannot be verified against its exchange. Apparently, Sinovac Biotech is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Sinovac Biotech Profile

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the Peoples Republic of China. Sinovac Biotech Ltd. was founded in 1999 and is based in Beijing, the Peoples Republic of China. Sinovac Biotech operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 735 people.. The public information regarding Sinovac Biotech Ltd's current market price is not available at this time.
NameSinovac Biotech Ltd
ChairmanWeidong YinView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
Business AddressNo. 15 Zhi Tong Road
ExchangeBATS Exchange
ISINAGP8696W1045
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.sinovacbio.com
Phone86 10 5693 1800
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 31, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJuly 15, 2019
Sinovac Biotech Ltd (SVA) is traded on BATS Exchange in USA and employs 735 people. The company currently falls under 'Small-Cap' category with total capitalization of 460.25 M. Sinovac Biotech runs under Healthcare sector within Biotechnology industry. The entity has 57.02 M outstanding shares of which 201.15 K shares are at this time shorted by investors with about 47.51 days to cover shorted positions. SINOVAC BIOTECH L has about 168.42 M in cash with 4.2 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04.
Check Sinovac Biotech Probability Of Bankruptcy

Sinovac Biotech Top Holders

Sinovac Biotech Key Fundamentals

Sinovac Biotech Against Markets

Sinovac Biotech Ltd cannot be verified against its exchange. Apparently, Sinovac Biotech is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the Peoples Republic of China. Sinovac Biotech Ltd. was founded in 1999 and is based in Beijing, the Peoples Republic of China. Sinovac Biotech operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 735 people.. The public information regarding Sinovac Biotech Ltd's current market price is not available at this time.
NameSinovac Biotech Ltd
ChairmanWeidong YinView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
Business AddressNo. 15 Zhi Tong Road
ExchangeBATS Exchange
ISINAGP8696W1045
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.sinovacbio.com
Phone86 10 5693 1800
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 31, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJuly 15, 2019

Sinovac Biotech Corporate Directors

Meng Mei Independent Director
Pengfei Li Director
Simon Anderson Independent Director
See also World Market Map. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.
Search macroaxis.com